Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/3/15 → 12/1/17 |
Funding
- Boehringer Ingelheim Pharmaceuticals ( Award # ): $8,000.00
1199,128: Multicenter, randomised, double-blind, Phase lll trial to investigate the efficacy and safetyof oral nintedanib plus docetaxel therapy compared to placebo plus docetaxel therapy in patients with stage lllB/IV or current, adenocarcinoma subtype
- Willis, Maurice (PI)
Project: Research project